ReviewArchives of microbiology2026
Alternative approaches in combating antimicrobial resistance in animals.
Review in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Neglected ESKAPE Pathogens in Companion Animals: Diagnostic Bias, Zoonotic Blind Spots, and Phytotherapeutic Opportunities.Pathogens (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The growing bacterial antimicrobial resistance is one of the most serious global challenges, undermining the effectiveness of conventional antibiotics and increasing morbidity and mortality across human and animal populations. Within the One Health framework, which emphasizes the interconnectedness of human, animal, and environmental health, interdisciplinary strategies are crucial for addressing this threat. Despite ongoing efforts, current approaches have not slowed the spread of resistant pathogens, underscoring a critical gap in the development of alternative therapeutics. This review addresses this gap by examining three promising strategies: phytotherapy (plant-derived antimicrobials), phage therapy (bacteriophage-based bacterial targeting), and antimicrobial peptides (membrane-disrupting bioactive molecules). These innovative approaches may serve as alternatives or adjuncts to traditional antimicrobials and are highly relevant to One Health applications. Emphasis is placed on their mechanisms of action, therapeutic efficacy, recent advances, and the challenges they pose for research.
Indexed as
Identifiers
41806028What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.